<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Here, we briefly review the role of the renin-angiotensin system (<z:mp ids='MP_0011356'>RAS</z:mp>) in <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and <z:hpo ids='HP_0002180'>neurodegenerative disease</z:hpo>, mainly discussing our experimental studies on the angiotensin II type 2 (AT(2) ) receptor </plain></SENT>
<SENT sid="1" pm="."><plain>Ischemic brain damage is enhanced in mice with overexpression of angiotensin II, with reduced cerebral blood flow in the penumbra and an increase in <z:mp ids='MP_0003674'>oxidative stress</z:mp> in the ischemic area </plain></SENT>
<SENT sid="2" pm="."><plain>Angiotensin II binds two types of receptors, type 1 (AT(1) ) and type 2 (AT(2) ) </plain></SENT>
<SENT sid="3" pm="."><plain>Our previous experiments showed that AT(1) receptor signaling has a harmful effect, and AT(2) receptor signaling has a protective effect on the brain after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>AT(2) receptor signaling in bone marrow stromal cells or hematopoietic cells was shown to prevent ischemic brain damage after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, AT(2) receptor signaling also affects cognitive function </plain></SENT>
<SENT sid="6" pm="."><plain>We showed that direct stimulation of the AT(2) receptor by a newly generated direct AT(2) receptor <z:chebi fb="4" ids="48705">agonist</z:chebi>, Compound 21 (C21), enhanced cognitive function in <z:mp ids='MP_0002169'>wild-type</z:mp> (C57BL6) mice and an <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> mouse model with intracerebroventricular injection of amyloid β (1-40) </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, we carried out clinical research by investigating the levels of <z:mp ids='MP_0011356'>RAS</z:mp> components in patients with <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>We observed a reduction of angiotensin II and angiotensin converting enzyme (ACE) 2 levels, and an increase in ACE level in cerebrospinal fluid from patients with multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that <z:mp ids='MP_0011356'>RAS</z:mp> is also involved in <z:hpo ids='HP_0002180'>neurodegenerative disease</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore, regulation of <z:mp ids='MP_0011356'>RAS</z:mp> might be a new therapeutic target to protect neurons from neural diseases </plain></SENT>
<SENT sid="11" pm="."><plain>Geriatr Gerontol Int 2012; ••: ••-•• </plain></SENT>
</text></document>